Furthermore, in AML studies, these CD200-induced Tregs were reportedly sufficient in suppressing T cell proliferation but appeared to have no impact in modulating Th1 cytokine release (TNF-α, IFN-γ, and IL-2) based on Treg depletion experiments [53]. This evidence concerns the gene IL2 and acute myeloid leukemia.